Cambridge Investment Research Advisors’s THERATECHNOLOGIES INC COM THER Stock Holding History

Cambridge Investment Research Advisors’s Portfolio THER Stock Details THER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,130	Closed	-$39K	–	3276
2021 Q2	$39K	Sell	10,130 -2,000	-16%	-$7.7K	﹤0.01%	3040
2021 Q1	$47K	Hold	12,130	–	–	﹤0.01%	2810
2020 Q4	$30K	Sell	12,130 -3,603	-23%	-$8.91K	﹤0.01%	2673
2020 Q3	$35K	Buy	15,733 +1,192	+8%	+$2.65K	﹤0.01%	2471
2020 Q2	$29K	Hold	14,541	–	–	﹤0.01%	2408
2020 Q1	$23K	Sell	14,541 -9,706	-40%	-$15.4K	﹤0.01%	2236
2019 Q4	$80K	Buy	+24,247	New	+$80K	﹤0.01%	2331

Other funds holding THER

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Cambridge Investment Research Advisors's THER Position: Q3 2021 in Review

Cambridge Investment Research Advisors sold out of THERATECHNOLOGIES INC COM (THER) in Q3 2021, closing a stake of 10,130 shares — an estimated $39K sold.

Cambridge Investment Research Advisors first reported a position in THER in Q4 2019 and held it in 7 quarters. The position peaked at $80K in Q4 2019. 41 funds tracked by Wall St. Rank hold THER as of Q3 2021.

Cambridge Investment Research Advisors reported no remaining THERATECHNOLOGIES INC COM position as of Q3 2021 after selling out during the quarter.
Cambridge Investment Research Advisors sold 10,130 THERATECHNOLOGIES INC COM shares in Q3 2021, an estimated $39K.
Cambridge Investment Research Advisors first reported a position in THERATECHNOLOGIES INC COM in Q4 2019 and held it in 7 quarters.
Cambridge Investment Research Advisors's THERATECHNOLOGIES INC COM position peaked at $80K in Q4 2019.
41 funds tracked by Wall St. Rank held THERATECHNOLOGIES INC COM as of Q3 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.